ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 648265 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 648265; 2) Community: the network communities that were significantly associated with the response to NSC 648265; 3) Molecule: the relationships between components within communities and NSC 648265; 4) MDR: the compounds that were significantly associated with the NSC 648265.

NSC Compound Enrichment Correlation
NSC 111533 Methoxycamptothecin 0.0244632509325736 -0.027883339
NSC 130862 Null 0.0244632509325736 0.37725833
NSC 184692 Aminopterin Derivative 0.0244632509325736 0.13814738
NSC 221266 Benzoic acid, 3,4-dichloro-, [1-[4-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]ethylidene]hydrazide, monohy 0.0244632509325736 0.10586946
NSC 243022 Cinerubin A hydrochloride 0.0244632509325736 0.29270909
NSC 245398 Null 0.0244632509325736 0.19806606
NSC 282880 Ethanaminium, 2-[[hydroxy(octadecyloxy)phosphinyl]oxy]-N,N,N-trimethyl-, inner salt (9CI) 0.0244632509325736 0.1965649
NSC 289922 Phosphonium, triphenyl-1-propenyl-, bromide, (E)- (9CI) 0.0244632509325736 0.16216643
NSC 320951 Bishelenalinyl malonate 0.0244632509325736 0.25548398
NSC 340847 4-Selenazolecarboxamide, 2-.beta.-D-ribofuranosyl- 0.0244632509325736 0.22669033
Total:112  Current:63    [First] [Prev] [Next] [Last]